id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2025-P-1304-0005,FDA,FDA-2025-P-1304,Response Letter,Other,Letter(s),2025-12-22T05:00:00Z,2025,12,2025-12-22T05:00:00Z,,2025-12-22T20:59:41Z,,0,0,09000064b90f7faf
FDA-2025-P-1304-0004,FDA,FDA-2025-P-1304,"Determination That EFFEXOR XR (Venlafaxine Hydrochloride) Extended- Release Capsule, 100 Milligrams, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness",Notice,Determinations,2025-12-19T05:00:00Z,2025,12,2025-12-19T05:00:00Z,,2025-12-19T21:21:26Z,2025-23408,0,0,09000064b90f5195
FDA-2025-P-1304-0003,FDA,FDA-2025-P-1304,"Interim Response Letter to SciRegs International, Inc. (on behalf of Inventia Healthcare Limited)",Other,Response(s),2025-11-14T05:00:00Z,2025,11,2025-11-14T05:00:00Z,,2025-11-15T02:25:45Z,,0,0,09000064b9081dc9
FDA-2025-P-1304-0002,FDA,FDA-2025-P-1304,"Acknowledgment Letter from FDA DMB to SciRegs International, Inc (on behalf of Inventia Healthcare Limited)",Other,Acknowledgement Letter/Receipt,2025-05-19T04:00:00Z,2025,5,2025-05-19T04:00:00Z,,2025-05-21T21:09:04Z,,0,0,09000064b8d82d6c
FDA-2025-P-1304-0001,FDA,FDA-2025-P-1304,"Citizen Petition from SciRegs International, Inc (on behalf of Inventia Healthcare Limited)",Other,Citizen Petition,2025-05-19T04:00:00Z,2025,5,2025-05-19T04:00:00Z,,2025-12-22T18:57:03Z,,0,0,09000064b8d751f2